Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

CRDF
Cardiff Oncology, Inc. Common Stock
stock NASDAQ

At Close
Jul 17, 2026 3:59:47 PM EDT
0.8800USD+0.435%(+0.0038)2,131,617
0.7500Bid   1.01Ask   0.2600Spread
Pre-market
Jul 17, 2026 9:28:30 AM EDT
0.8985USD+2.744%(+0.0240)76,253
After-hours
Jul 17, 2026 4:58:30 PM EDT
0.8892USD+1.241%(+0.0109)24,200
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
06:23PM EST  Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)   PR Newswire
Jan 20, 2022
01:47PM EST  Cardiff Oncology to Present at the B. Riley Securities 2022 Oncology Conference   PR Newswire
Jan 19, 2022
02:38PM EST  Mid-Afternoon Market Update: Dow Tumbles 150 Points; Yumanity Therapeutics Shares Plunge   Benzinga
12:26PM EST  Mid-Day Market Update: US Stocks Turn Negative; Zogenix Shares Spike Higher   Benzinga
11:48AM EST  California-based healthcare company, Cardiff Oncology, Inc. (CRDF) plummeted 23% on Wednesday after the company published the results from its Lead Clinical Program in KRAS-mutated Metastatic Colorectal Cancer that showed a drop in the percentage of patients who showed partial response.   RTTNews
10:27AM EST  Mid-Morning Market Update: Markets Rise; Bank of America Posts Upbeat Profit   Benzinga
07:40AM EST  The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data   Benzinga
Jan 18, 2022
05:02PM EST  Cardiff Oncology Announces New Data From Lead Clinical Program In KRAS-Mutated Metastatic Colorectal Cancer Showing Robust Objective Response Rate And Progression Free Survival   Benzinga
05:00PM EST  Metastatic Colorectal Cancer Showing Robust Objective Response Rate and Progression Free Survival   PR Newswire
Jan 16, 2022
04:38PM EST  The Week Ahead In Biotech (Jan 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week   Benzinga
Jan 11, 2022
08:01AM EST  Cardiff Oncology Appoints Tod Smeal, Ph.D., as Chief Scientific Officer and   PR Newswire
Jan 10, 2022
08:05AM EST  Cardiff Oncology To Host Conference Call And Webcast To Discuss Updated Data From Lead Clinical Program In KRAS-mutated Metastatic Colorectal Cancer Being Presented At 2022 American Society Of Clinical Oncology Gastrointestinal Cancers Symposium   Benzinga
08:01AM EST  from Lead Clinical Program in KRAS-mutated Metastatic Colorectal Cancer Being Presented at the 2022 American Society of Clinical Oncology Gastrointestinal Cancers Symposium   PR Newswire
Jan 4, 2022
08:03AM EST  Cardiff Oncology to Present at the H.C. Wainwright BioConnect Virtual Conference   PR Newswire
Dec 10, 2021
08:32AM EST  Cardiff Oncology Announces Upcoming Presentation On Lead KRAS-Mutated Metastatic Colorectal Cancer Program At 2022 American Society Of Clinical Oncology Gastrointestinal Cancers Symposium   Benzinga
08:31AM EST  Metastatic Colorectal Cancer Program at the 2022 American Society of Clinical Oncology Gastrointestinal Cancers Symposium   PR Newswire
Dec 8, 2021
10:04AM EST  Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021   Benzinga
05:08AM EST  Baird Initiates Coverage On Cardiff Oncology with Outperform Rating, Announces Price Target of $19   Benzinga
Dec 3, 2021
08:31AM EST  Cardiff Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   PR Newswire
Nov 18, 2021
07:24AM EST  Pfizer Inc. (PFE) has made a $15 million equity investment in Cardiff Oncology Inc. (CRDF), as part of the Pfizer Breakthrough Growth Initiative, Cardiff said in a statement on Thursday.   RTTNews
07:05AM EST  Cardiff Oncology Announced $15M Equity Investment from Pfizer through its Pfizer Breakthrough Growth Initiative   Benzinga
07:03AM EST  Pfizer Invests $15 Mln In Cardiff Oncology Common Shares; Stock Surges   RTTNews
07:02AM EST  Cardiff Oncology Announces $15 Million Equity Investment from Pfizer through   PR Newswire
Nov 9, 2021
08:31AM EST  Cardiff Oncology to Present at Upcoming Jefferies London Healthcare and Piper   PR Newswire
Nov 5, 2021
09:32AM EDT  Cardiff Oncology Q3 EPS $(0.17) Up From $(0.19) YoY, Sales $86.00K Down From $136.00K YoY   Benzinga
Nov 4, 2021
04:16PM EDT  Cardiff Oncology Reports Third Quarter 2021 Results and Provides Business   PR Newswire
Sep 9, 2021
08:17AM EDT  The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization   Benzinga
05:35AM EDT  The following are some of the stocks making big moves in Thursday's pre-market trading (as of 5.25 A.M. EDT).   RTTNews
Sep 8, 2021
04:04PM EDT  Cardiff Oncology Announces New Data From Phase 1b/2 Trial In KRAS-mutated Metastatic Colorectal Cancer   RTTNews
04:03PM EDT  UPDATE: Cardiff Says 42% Of Patients Treater Per Protocol At Recommend Dose Who Were Evaluable For Disease Response As Of Cut-Off Achieved A Partial Response   Benzinga
04:02PM EDT  Cardiff Oncology Announces New Data From Phase 1b/2 Trial In KRAS-Mutated Metastatic Colorectal Cancer Showing 'Robust Objective Response Rate And Progression Free Survival'   Benzinga
04:01PM EDT  Cardiff Oncology Announces New Data From Phase 1b/2 Trial In KRAS-Mutated Metastatic Colorectal Cancer Showing Robust Objective Response Rate And Progression Free Survival   Benzinga
04:01PM EDT  Metastatic Colorectal Cancer Showing Robust Objective Response Rate and Progression Free Survival   PR Newswire
07:32AM EDT  The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod   Benzinga
Sep 7, 2021
08:32AM EDT  Cardiff Oncology to Present at Upcoming Investor Conferences in September   PR Newswire
Sep 5, 2021
01:14PM EDT  The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week   Benzinga
Aug 25, 2021
08:21AM EDT  Cardiff Oncology To Present New Data From Lead Clinical Program In KRAS-mutated Metastatic Colorectal Cancer On Sept 8   RTTNews
08:15AM EDT  Cardiff Oncology to Present New Data from Lead Clinical Program in KRAS-mutated   PR Newswire
08:15AM EDT  Cardiff Oncology To Present New Data From Lead Clinical Program In KRAS-Mutated Metastatic Colorectal Cancer On September 8, 2021   Benzinga
Aug 10, 2021
06:35AM EDT  HC Wainwright & Co. Maintains Buy on Cardiff Oncology, Raises Price Target to $26   Benzinga
Aug 5, 2021
06:04PM EDT  Cardiff Oncology Q2 EPS $(0.17) Up From $(0.51) YoY   Benzinga
04:16PM EDT  Cardiff Oncology Reports Second Quarter 2021 Results and Provides Business   PR Newswire
Jul 12, 2021
08:26AM EDT  Cardiff Oncology Names Katherine Katherine As Chief Medical Officer, Names James E. Levine As CFO   Benzinga
08:06AM EDT  Cardiff Oncology Says Appoints James Levine As CFO   RTTNews
Jul 6, 2021
08:31AM EDT  Cardiff Oncology to Participate in a Fireside Chat at the William Blair Biotech   PR Newswire
Jun 28, 2021
08:31AM EDT  Cardiff Oncology Added to the Russell 2000(r) and other FTSE Russell Indexes   PR Newswire
Jun 10, 2021
12:30PM EDT  Cardiff Oncology Announces the Appointment of Two New Independent Members to   PR Newswire
Jun 8, 2021
08:41AM EDT  Cardiff Oncology Announces First Patient Dosed In Phase 2 Trial Of Onvansertib In Combination With Irinotecan And 5-FU In Pancreatic Cancer   Benzinga
08:37AM EDT  Cardiff Oncology Doses First Patient In Phase 2 Trial Of Onvansertib With Irinotecan And 5-FU In Pancreatic Cancer   RTTNews
08:30AM EDT  Onvansertib in Combination with Irinotecan and 5-FU in Pancreatic Cancer   PR Newswire
May 20, 2021
08:31AM EDT  Cardiff Oncology to Present at the Jefferies Virtual Healthcare Conference   PR Newswire
May 10, 2021
07:13AM EDT  HC Wainwright & Co. Maintains Buy on Cardiff Oncology, Lowers Price Target to $25   Benzinga
May 6, 2021
05:24PM EDT  Cardiff Oncology Q1 EPS $(0.14) Up From $(0.41) YoY   Benzinga
04:11PM EDT  Cardiff Oncology Announces First Quarter 2021 Results and Recent Highlights   PR Newswire
May 5, 2021
10:10AM EDT  Let's Take A Look At This Weeks Top Performing Sectors 5/5   Benzinga
Apr 12, 2021
10:19AM EDT  Cardiff Oncology's Onvansertib Shows Durable Response, Progression-Free Survival In Colorectal Cancer Patients   Benzinga
10:05AM EDT  Cardiff Oncology Saturday Morning Announced Collab With MIT To Present Gene Signature Analyses Data Identifying Androgen-Independent Mechanism for Onvansertib-Abiraterone Synergy in mCRPC   Benzinga
10:00AM EDT  Cardiff Oncology Saturday Morning Announced Presentation Of Findings From Expanded Access Program For Metastatic KRAS-Mutated mCRC Trial At American Association For Cancer Research Conference   Benzinga
06:09AM EDT  Cardiff Oncology: Onvansertib Phase 1b/2 Data Continues To Demonstrate Robust Response In KRAS-Mutated MCRC   RTTNews
06:04AM EDT  Cardiff Oncology Announces Onvansertib Phase 1b/2 Data that Continues to Demonstrate Robust Response to Treatment and Progression-Free Survival in KRAS-Mutated mCRC   Benzinga
06:01AM EDT  Demonstrate Robust Response to Treatment and Progression-Free Survival in KRAS-Mutated mCRC   PR Newswire
Apr 10, 2021
08:30AM EDT  Data Identifying Androgen-Independent Mechanism for Onvansertib-Abiraterone Synergy in mCRPC   PR Newswire
08:30AM EDT  Highlighting the Clinical Benefit of Onvansertib in Heavily Pretreated Patients with Metastatic KRAS-Mutated mCRC   PR Newswire
Apr 8, 2021
08:31AM EDT  Cardiff Oncology to Host Key Opinion Leader Webinar on Onvansertib for the   PR Newswire
Mar 11, 2021
08:31AM EST  Cardiff Oncology to Present at the Oppenheimer 31st Annual Healthcare Conference   PR Newswire
Mar 10, 2021
04:30PM EST  Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting   PR Newswire
Mar 3, 2021
08:31AM EST  Cardiff Oncology to Present at H.C. Wainwright Global Life Sciences Conference   PR Newswire
Feb 25, 2021
05:16PM EST  Cardiff Oncology Q4 EPS $(0.19) Up From $(0.51) YoY, Sales $119.00K Up From $93.00K YoY   Benzinga
04:25PM EST  Cardiff Oncology Announces Fourth Quarter and Full Year 2020 Results and Recent   PR Newswire
Feb 24, 2021
08:31AM EST  Pancreatic Cancer Panel Discussion at the Cowen 41st Annual Health Care Conference   PR Newswire
Feb 16, 2021
11:55AM EST  Cardiff Oncology to Present at the LifeSci Partners Precision Oncology Day   PR Newswire
Feb 11, 2021
11:21AM EST  Cardiff Oncology's Onvansertib Combo Associated With Two-Fold Increase Disease Control Rate In Prostate Cancer Study   Benzinga
08:22AM EST  Cardiff : Phase 2 MCRPC Trial Data Shows Two-Fold Increase In Efficacy With Optimized Onvansertib Dosing Schedule   RTTNews
08:02AM EST  Cardiff Oncology Presents Phase 2 mCRPC Trial Data Showing a Two-Fold Increase   PR Newswire
Feb 5, 2021
02:00AM EST  Tiziana Life Sciences plc (NASDAQ: TLSA / LSE: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announces the appointment of Dr. Thomas Adams, Ph.D. as an executive director.   GlobeNewswire Inc
Jan 26, 2021
08:28AM EST  Cardiff Oncology Gets "Study May Proceed" From FDA To Initiate Phase 2 Trial Of Onvansertib In Metastatic PDAC   RTTNews
08:09AM EST  Cardiff Oncology Receives 'Study May Proceed' Letter From FDA To Initiate Phase 2 Trial Pf Onvansertib In Metastatic Pancreatic Ductal Adenocarcinoma   Benzinga
08:02AM EST  Cardiff Oncology Receives "Study May Proceed" from FDA to Initiate Phase 2   PR Newswire
Jan 15, 2021
02:48PM EST  Mid-Afternoon Market Update: Dow Down 70 Points; Atlantic Power Shares Spike Higher   Benzinga
12:29PM EST  Mid-Day Market Update: Crude Oil Down Over 2%; DBV Technologies Shares Jump   Benzinga
10:17AM EST  Mid-Morning Market Update: Markets Open Lower; JPMorgan Beats Q4 Estimates   Benzinga
08:20AM EST  Cardiff Oncology Presents Data From Phase 1b/2 Study In KRAS-mutated Metastatic Colorectal Cancer   RTTNews
08:07AM EST  Cardiff Oncology Presents Data That Continues To Demonstrate The Clinical Benefit Of Onvansertib In KRAS-Mutated mCRC, Initial Findings From Expanded Access Program   Benzinga
08:01AM EST  Benefit of Onvansertib in KRAS-Mutated mCRC and Initial Findings from its Expanded Access Program   PR Newswire
Dec 22, 2020
07:45AM EST  The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes   Benzinga
Dec 21, 2020
04:19PM EST  Cardiff Oncology Appoints Rodney Markin As Chairman Of Board   RTTNews
04:17PM EST  Cardiff Oncology Announces Appointment Of Dr. Rodney Markin As Chairman Of The Board   Benzinga
04:15PM EST  Cardiff Oncology Announces the Appointment of Dr. Rodney Markin as Chairman of   PR Newswire
Dec 16, 2020
10:00AM EST  10 Healthcare Stocks That Thrived In 2020   Benzinga
Dec 6, 2020
08:30AM EST  Anti-Leukemic Activity of Onvansertib in Patients with Relapsed/Refractory AML   PR Newswire
Dec 2, 2020
07:35AM EST  The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod   Benzinga
Dec 1, 2020
08:08AM EST  The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit   Benzinga
Nov 25, 2020
07:35AM EST  The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback   Benzinga
Nov 24, 2020
08:13AM EST  The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia   Benzinga
Nov 23, 2020
08:31AM EST  Cardiff Oncology to Participate in Fireside Chat at the Piper Sandler 32nd   PR Newswire
Nov 5, 2020
05:10PM EST  Cardiff Oncology Q3 EPS $(0.19) Up From $(0.71) YoY   Benzinga
04:06PM EST  Cardiff Oncology Announces Third Quarter 2020 Results and Highlights   PR Newswire
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
Oct 22, 2020
11:11AM EDT  Benzinga's Top Upgrades, Downgrades For October 22, 2020   Benzinga
10:38AM EDT  Why Cardiff Oncology's Stock Is Trading Higher Today   Benzinga
06:48AM EDT  HC Wainwright & Co. Initiates Coverage On Cardiff Oncology with Buy Rating, Announces Price Target of $27   Benzinga
Oct 20, 2020
08:34AM EDT  Cardiff Oncology Highlights Presentation Of Efficacy And Biomarker Data From mCRPC Trial Of Onvansertib At 27th Annual Prostate Cancer Foundation (PCF) Scientific Retreat   Benzinga
08:31AM EDT  Cardiff Oncology Presents Positive Efficacy and Biomarker Data from mCRPC Trial   PR Newswire
Oct 8, 2020
10:00AM EDT  Benzinga's Top Upgrades, Downgrades For October 8, 2020   Benzinga
05:15AM EDT  Piper Sandler Initiates Coverage On Cardiff Oncology with Overweight Rating, Announces Price Target of $25   Benzinga
Sep 30, 2020
05:43AM EDT  Cardiff Oncology Priced 6.5M Share Public Offering @$13.50/Share   Benzinga
12:31AM EDT  Cardiff Oncology Reports Pricing Of Public Offering Of 6.5 Mln Shares At $13.50/Shr   RTTNews
12:15AM EDT  Cardiff Oncology Prices Public Offering   PR Newswire
Sep 29, 2020
04:05PM EDT  Cardiff Oncology Announces A Common Stock Offering; No Terms Disclosed   Benzinga
04:03PM EDT  Cardiff Oncology Announces Proposed Public Offering   RTTNews
04:03PM EDT  Cardiff Oncology Announces A Common Stock Offering   Benzinga
04:02PM EDT  Cardiff Oncology Announces Proposed Public Offering   PR Newswire
Sep 21, 2020
10:21AM EDT  Mid-Morning Market Update: Markets Open Lower; Microsoft To Acquire Game Maker ZeniMax For $7.5B   Benzinga
Sep 18, 2020
10:43AM EDT  Maxim Group Maintains Buy on Cardiff Oncology, Raises Price Target to $14   Benzinga
Sep 17, 2020
02:57PM EDT  Why Cardiff Oncology's Stock Is Trading Higher Today   Benzinga
02:09PM EDT  Cardiff Oncology Option Alert: Fri $7.5 Calls Sweep (9) near the Ask: 175 @ $2.7 vs 4242 OI; Earnings 11/5 After Close [est] Ref=$9.9999   Benzinga
01:15PM EDT  Cardiff Oncology shares are trading higher after the company presented positive onvansertib data.   Benzinga
11:03AM EDT  Insider Buys Cardiff Oncology's Shares   Benzinga
08:08AM EDT  Cardiff Oncology Highlights Presentation Of Data At ESMO 'Confirming Efficacy of Onvansertib and Durability of Response in KRAS-Mutated Metastatic Colorectal Cancer (mCRC)'   Benzinga
08:02AM EDT  Cardiff Oncology Presents Data at ESMO Confirming Efficacy of Onvansertib and   PR Newswire
Sep 15, 2020
08:31AM EDT  Colorectal Cancer and Highlighting Data from Onvansertib Phase 1b/2 Trial   PR Newswire
Sep 14, 2020
08:31AM EDT  Cardiff Oncology to Present Data Further Demonstrating the Safety and Efficacy   PR Newswire
Aug 19, 2020
03:16PM EDT  Cardiff Oncology Option Alert: Sep 18 $7.5 Calls at the Ask: 1500 @ $1.0 vs 84 OI; Ref=$6.54   Benzinga
Aug 11, 2020
04:26PM EDT  Cardiff Oncology Q2 EPS $(0.51) Up From $(0.76) YoY   Benzinga
04:15PM EDT  Cardiff Oncology Announces Second Quarter 2020 Results and Highlights   PR Newswire
Aug 6, 2020
07:57AM EDT  The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO   Benzinga
Aug 4, 2020
08:31AM EDT  Cardiff Oncology to Participate in Fireside Chat at the Virtual BTIG   PR Newswire
Jul 30, 2020
08:31AM EDT  Cardiff Oncology to Participate in the William Blair Biotech Focus Conference   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC